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Abstract
Background: The aim of this research was to study the clinical characteristics and mortality and disability outcomes of
patients who present distinct risk profiles for functional decline at admission.
Methods: Multicenter, prospective cohort study conducted between 2006 and 2009 in three hospitals in the Netherlands in
consecutive patients of $65 years, acutely admitted and hospitalized for at least 48 hours. Nineteen geriatric conditions
were assessed at hospital admission, and mortality and functional decline were assessed until twelve months after
admission. Patients were divided into risk categories for functional decline (low, intermediate or high risk) according to the
Identification of Seniors at Risk-Hospitalized Patients.
Results: A total of 639 patients were included, with a mean age of 78 years. Overall, 27%, 33% and 40% of the patients were
at low, intermediate or high risk, respectively, for functional decline. Low-risk patients had fewer geriatric conditions (mean
2.2 [standard deviation [SD] 1.3]) compared with those at intermediate (mean 3.8 [SD 2.1]) or high risk (mean 5.1 [SD 1.8])
(p,0.001). Twelve months after admission, 39% of the low-risk group had an adverse outcome, compared with 50% in the
intermediate risk group and 69% in the high risk group (p,0.001).
Conclusion: By using a simple risk assessment instrument at hospital admission, patients at low, intermediate or high risk
for functional decline could be identified, with distinct clinical characteristics and outcomes. This approach should be tested
in clinical practice and research and might help appropriately tailor patient care.
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Introduction
Functional decline, defined as a loss of activities of daily living
(ADL), is experienced by 30 to 60% of hospitalized older patients
[1,2]. In acutely hospitalized patients, functional decline often
precedes hospital admission [3], and hospitalization itself further
increases the risk of worsening ADL disabilities [4]. Patients with
functional decline are also at risk for other adverse health
outcomes, such as institutionalization and death [5].
Preventing functional decline during and after hospitalization is
therefore an increasingly important health-care focus in older
hospital patients [6,7]. Not all patients are at equal risk of
developing functional decline because decline is dependent on
(among other factors) patients’ premorbid status, including
geriatric conditions present at admission [1,8]. The aggregate
number of geriatric conditions present at hospital admission
determines a patient’s individual risk for functional deterioration
[1,9].
In studies focusing on assessing the risk of functional decline, the
study population is often crudely dichotomized into a low-risk and
a high-risk group [5]. Both the International Classification of
Functioning (ICF) and expert opinion suggest the need for patient
care and research to adopt a more tailored approach, in which
different subgroups or categories of older patients are identi-
fied.[7–10]. The added value of such an approach is that it might
help clinicians define subtle treatment goals at an early stage (for
instance, at hospital admission), discuss preferred and expected
hospital care outcomes with their patients and it might enhance
clinical decision making. Although some studies have attempted to
develop an approach using more than two subgroups of patients
[11,12], the clinical characteristics and outcomes of these patients
groups have not been described and studied thoroughly [13].
The objectives of this multicenter, prospective, observational
study were therefore to investigate 1) differences in the clinical
characteristics of patients at low, intermediate or high risk for
functional decline, 2) the different functional trajectories from
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association between risk categories and mortality and functional
decline at three and twelve months after hospital admission.
Methods
Design and setting
This multicenter prospective cohort study, the DEFENCE study
(Develop strategies Enabling Frail Elderly New Complications to
Evade) was conducted between April 1, 2006 and April 1, 2008 in
three hospitals in The Netherlands: the Academic Medical Center
(AMC) in Amsterdam, the University Medical Centre Utrecht
(UMCU) in Utrecht and the Spaarne Hospital (SH) in Hoofddorp.
The AMC (1,024 beds) and UMCU (1,042 beds) are tertiary
university teaching hospitals. The SH (455 beds) is a regional
teaching hospital.
In total, five wards in the AMC, three wards in the UMCU and
three wards in the SH participated in this study. The staff on the
general medical wards consisted of residents, physicians and
registered nurses who did not specialize in geriatric medicine or
geriatric nursing. A geriatric consultation team consisting of at
least one clinical nurse specialist and one geriatrician was available
in all hospitals.
The study was approved by the Medical Ethics Committee of
the AMC. Local approval was given by the UMCU and SH.
Patients
The study enrolled all consecutive patients aged 65 years and
older who were acutely admitted to one of the three participating
hospitals’ medical wards and hospitalized for at least 48 hours.
Patients were excluded if 1) they or their relatives did not give
informed consent; 2) they were too ill to participate, as determined
by their attending medical doctor; 3) they came from another ward
in or outside the hospital; 4) they were transferred to the Intensive
Care Unit of the Coronary Care Unit or another ward in or
outside the hospital within 48 hours after admission; or 5) they
were unable to speak or understand Dutch. Enrollment had to
take place within 48 hours after admission, and written informed
consent was obtained before inclusion.
Data collection
A research nurse visited the participating wards every weekday
seeking eligible patients for the study. After obtaining informed
consent from the patient or, in case of cognitive impairment, from
the primary caregiver, the patient received a risk assessment,
followed by a systematic geriatric assessment on four domains of
functioning (somatic, psychological, functional and social) per-
formed by the research nurse. The primary caregiver was also
interviewed. The patient assessment had to be completed within
48 hours after admission.
Risk assessment for functional decline
The Identification of Seniors at Risk–Hospitalized Patients
(ISAR-HP) was applied to determine which patients were at low,
intermediate or high risk for functional decline. The ISAR-HP is
based on the original ISAR for the Emergency Department (ED)
[14]. The ISAR has been validated to detect a broad range of
adverse outcomes after Emergency Department discharge and has
been shown to be a clinimetrically sound screening instrument
[14–16]. The original ISAR was tested on its predictive accuracy
in acutely hospitalized older medical patients, but did not show
good discriminative values in this population [17]. Therefore, a
new prediction model was developed in an independent
population and externally validated to assess the risk of functional
decline three months after hospital admission in older hospitalized
patients. The complete procedure is described in another article
[18] . Briefly, in the development study (n=492) potential
predictors associated with functional decline were identified using
univariate logistic regression. Items of the original ISAR screening
instrument [14], of the IADL index of Lawton and Brody [19], of
the Short Nutritional Assessment Questionnaire [20] and other
predictors known from the literature were analyzed as individual
predictors. Next, a multivariate logistic regression was conducted
(backward procedure, accepting P-values#0.05). The four best
models were compared and validated in a bootstrap procedure
(1000 samples drawn randomly with replacement) using the AUC
with 95% CI to determine the discriminative value. The AUC of
the best model was 0.71 (95% CI 0.66–0.76) and the Hosmer
Lemeshow test showed a p-value of 0.95, indicating a good fitting
model. The validation cohort consisted of a retrospective analysis
of a cohort of 484 patients acutely admitted to general medicine
ward; the AUC of the prediction model in the validation cohort
was 0.68 (95% CI 0.63–0.73).
The screening instrument was named ISAR-HP (with permis-
sion of the original author) and consists of four variables 1) the
need for assistance with instrumental activities of daily living
(IADL) two weeks prior to hospital admission, 2) eight years or
fewer of formal education, 3) the inability to travel alone two weeks
prior to hospital admission and 4) the use of a walking device. The
first three items scored one point each, and the last item scored
two points. Patients were at risk for functional decline if the ISAR-
HP was 2 points or more. Definition of risk categories applied in
this article: low risk if patients scored 0 or 1 point on the ISAR-
HP, at intermediate risk if they scored 2 or 3 points and at high
risk if patients had a score of 4 or 5.
Systematic geriatric assessment
At admission, patients’ baseline and clinical characteristics were
assessed with a comprehensive geriatric assessment (CGA). Table
S1 shows the measurement tools, score ranges and cut-off scores
used during this assessment. The CGA started with the eleven-
item Minimal Mental State Examination (MMSE) [21] to assess
the presence and degree of global cognitive impairment. Patients
with a MMSE score $21 were interviewed; patients with a MMSE
score of 16–20 were also interviewed, but their answers concerning
baseline characteristics and ADL performances were cross-
checked with their caregiver. In case of a disagreement, the
caregiver’s answer was included. Data for patients with an MMSE
score #15 were obtained from their primary caregiver. This latter
group was not screened for pain, depression or perceived health
status, as the instruments we used have not been validated with
cognitively impaired patients.
After administering the comprehensive geriatric assessment, the
research nurse reported her findings to the geriatrician. The
geriatrician also visited each patient within 48 hours and paid
special attention to diagnosing potential psychiatric problems. The
patient was screened for delirium using the confusion assessment
method (CAM) [22].
After discharge, a geriatrician reviewed the discharge letter to
determine the medical diagnoses presented at admission, new
diagnoses developed during the patient’s hospital stay, comor-
bidities and medication. Charlson comorbidity index scores
were derived from this information [23], indicating the number
and severity of comorbidities. Charlson comorbidity index
scores range from 0 to 31, with a higher score indicating an
increased number of severe comorbidities. International Clas-
sification of Diseases-9 diagnostic criteria were used to score
these diagnoses.
Clinical Profiles and Risk for Functional Decline
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Three and twelve months after admission, a research nurse from
each center phoned the patient and/or primary caregiver to assess
the patient’s current ADL functioning. ADL status was collected
from the same person (patient or informal caregiver) from whom
the baseline information was obtained. Functional decline was
defined as a loss of at least one point on the original Katz ADL
index score [24] three or twelve months after admission, compared
with the premorbid Katz ADL index score two weeks prior to
hospital admission.
The mortality rate at three months and twelve months after
admission was based on information from the Municipal Data
Registry.
Functional trajectories were defined as the course of functioning
from admission up to one year after discharge and were
constructed using mortality and functional decline data at each
time point. Patients who were still alive at three and twelve months
and did not demonstrate decreased ADL functioning remained at
their baseline level of function.
Statistical analysis
Baseline characteristics and outcomes were summarized using
descriptive statistics. To determine the differences in the
prevalence of geriatric conditions and outcomes among patients
at low, intermediate and high risk for functional decline,
dichotomous variables and categorical data were tested with a
chi-squared test, and continuous variables were tested using
ANOVA. For some geriatric conditions there were missing values.
To gain more insight in the functional trajectories until one year
after admission in relation to the ISAR-HP two strategies were
followed. One strategy was to calculate the individual responses to
the ISAR-HP questions, and to compute the mean number of
baseline and follow up scores on the Katz ADL index and the
mean number of ADL functions that were lost between baseline
and follow up. To establish functional trajectories including
mortality at three and twelve months, the number of patients who
had died and who demonstrated functional decline in each risk
group was calculated. Patients who improved in activities of daily
living were added to the group that remained at baseline
functional levels. This was set out in figure 1.
To determine the relationship between risk category and
mortality and functional decline at three and twelve months,
regression analyses were performed. For mortality, Cox regression
analyses were performed. Crude and adjusted (for age, sex and
Charlson comorbidity index) models were calculated. For
functional decline, logistic regression analyses were conducted
Figure 1. Functional trajectories for patients at low, intermediate or high risk for functional decline three and twelve months after
admission. ‘‘Baseline function’’ refers to the level of premorbid functioning on the Katz ADL index score two weeks prior to hospital admission. A
decline in function was defined as a loss of at least one point at three or twelve months on the six-item Katz ADL index compared with premorbid
functioning.
doi:10.1371/journal.pone.0029621.g001
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same factors. Patients in the low-risk group were used as a
reference category.
Results
There were 1,031 consecutive patients eligible for participation
in this study, 639 (62%) of whom were included after informed
consent. Reasons for exclusion were refusal to participate
(n=222), insufficient Dutch language capabilities (n=86), transfer
from another ward (n=36), transfer to Intensive Care Unit or
Coronary Care Unit within 48 hours (n=28) and terminal illness
(n=20). Compared with included patients, excluded patients were
significantly younger (75 years vs. 78 years, p,0.001) and died
more frequently within one year (48% vs. 35%, p,0.001).
Baseline characteristics of the three risk groups
Table 1 presentsthe baselinecharacteristicsofthecomplete study
population. The mean age was 78 years; 72% lived independently
before hospital admission and approximately half the patients lived
alone. The most common reason for admission was infection (41%).
ISAR-HP scores showed that 27%, 33% and 40% of the patients
were at low, intermediate or high risk for functional decline,
respectively. There was a significant relationship between higher
risk levels and older age, female sex, fewer years of education/lower
social status, living alone, and care dependency.
Clinical characteristics
Table 2 shows the clinical characteristics of patients at low,
intermediate or high risk for functional decline. Patients at high risk
for functional decline had more geriatric conditions (mean 5.1
[SD 1.8]) than those at low risk (mean 2.2 [SD 1.3]) or intermediate
risk (mean 3.8 [SD 2.1]) for decline (p,0.001). In the high-risk group,
patients frequently presented geriatric syndromes, such as fall risk,
incontinence, premorbid cognitive impairment and delirium. As
expected,therewasalsoasubstantialcaregiverburdeninthehigh-risk
group.
We could not demonstrate clear differences between the
subgroups with regard to malnutrition, obesity, pain, constipation
or depressive symptoms.
Functional trajectories at three and twelve months
The mean number of baseline impairments on the modified
Katz ADL index differed significantly between the three risk
groups (0.1, 1.2, 2.4, p,0.001, Table 3). In the low risk group only
13% experienced one or more dependencies in ADL, whereas in
the high risk group this was 77%, with 11% demonstrating
complete dependence. The mean decline experienced until one
year after discharge was also significantly different. Outcomes in
terms of mortality and functional decline three and twelve months
after hospital admission differed significantly between the groups
(Figure 1). After three months, 25% of the low-risk group had a
poor outcome (mortality or functional decline), compared with
40% and 59% in the intermediate- and high-risk groups,
respectively (p,0.001). At twelve months, these rates were 39%,
50% and 69% for the low-, intermediate- and high-risk group,
respectively (p,0.001). Only 30% of the patients in the high-risk
group remained at their baseline level of functioning at twelve
months. Although the high-risk patients had the most premorbid
Table 1. Baseline characteristics of acutely hospitalized older patients in three risk categories for physical functional decline.
Patients n=639
Low risk
(n=175)
Intermediate risk
(n=211)
High risk
(n=253) p-value
Age in years 78.2 (7.8) 73.8 (6.4) 77.4 (7.1) 82.0 (7.5) ,0.001
Male (%) 46.2 60.0 46.9 36.0 ,0.001
Education in years 9.9 (3.9) 11.4 (3.8) 10.2 (3.9) 8.6 (3.6) ,0.001
Caucasian (%) 92.8 95.4 91.9 91.7 0.35
Social status (%) ,0.001
Living alone 47.9 37.1 46.7 56.3
Living arrangement (%) ,0.001
Independent 72.4 93.7 78.6 52.6
Senior residence 10.3 4.6 9.0 15.4
Supported living community 10.3 0.6 6.7 20.2
Nursing home/intermediate care 7.0 1.1 5.8 11.8
Diagnosis at admission (%) 0.76
Infectious disease 40.9 42.9 45.5 35.9
Digestive system disease 22.8 23.8 21.8 22.9
Malignancy 6.2 8.3 4.5 6.1
Cardiovascular disease 4.3 4.8 2.7 5.3
Water and electrolyte disturbance 10.5 9.5 8.2 13.0
Other 15.4 10.7 17.3 16.8
Charlson comorbidity index* 3.5 (2.3) 3.9 (2.7) 3.8 (2.4) 3.5 (2.2) 0.27
Length of hospital stay in days (median [range]) 7 (2–100) 5 (2–100) 7 (2–77) 8 (2–80) 0.01
Mean (SD) are given for continuous variables.
*Range 0–31; a higher score indicates more or more severe comorbidities.
doi:10.1371/journal.pone.0029621.t001
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twelve months.
Risk profiles in relation to mortality and functional
decline
Tables 4 and 5 show that in both the crude and adjusted
models, being at high risk for functional decline was significantly
associated with mortality and poor functional health at both time
points. Among patients at intermediate risk, the only significant
association was found for functional decline at three and twelve
months. However, when adjusting for age, sex and level of
comorbidity, we could not demonstrate an association between
moderate risk and functional decline one year after discharge.
Discussion
This multicenter study showed that by applying a simple risk
assessment instrument at admission, three subgroups of older
patients with distinct clinical characteristics and outcomes could be
identified. Twenty-seven percent of the patients were at low risk
for functional decline, 33% were at intermediate risk and 40%
were at high risk for developing new disabilities. Patients at high
risk for further functional decline presented with the highest
number of geriatric conditions. High-risk patients were also at the
highest risk for poor outcomes in terms of mortality and
deterioration in ADL functioning and their mean overall decline
in functioning was significantly greater.
The low-risk group, as expected, presented with the fewest
geriatric conditions and ADL impairments at admission but still
had an average of two geriatric conditions besides the acute and
chronic diseases leading to hospital admission. The number of
geriatric conditions and premorbid ADL impairments gradually
increased in the intermediate- and high-risk groups. The findings
on the differences between the subgroups are consistent with other
studies that used a more detailed risk classification for functional
decline or frailty [9,13].
The geriatric conditions most often present in the high-risk
group (cognitive impairment, delirium, premorbid ADL impair-
ment, urine incontinence and fall risk) reflect the patients’ frailty
[25,26] and are known risk factors for future functional decline
[1,8,26,27] . The high-risk group presented with the most baseline
impairments and the greatest deterioration of ADLs both in
percentage and the mean number of decline over the follow-up
period. Lost functions are difficult to recover, and new disabilities
or impairment reported at discharge that are still present at one
month of follow-up are especially difficult to rehabilitate [27].
Patients discharged with new or additional disabilities also have
the highest probability of dying in the year after admission [27].
Table 2. Clinical characteristics of acutely hospitalized older patients in the three risk categories for physical functional decline.
Low risk n=175% (n/total
number of observations)
Intermediate risk n=211%
(n/total number of
observations)
High risk n=253% (n/total
number of observations) p-value
Somatic domain
Polypharmacy 46.6 (81/174) 64.8 (136/210) 66.3 (167/252) ,0.001
Malnutrition 45.2 (76/168) 50.5 (105/208) 54.6 (136/249) 0.17
Obesity 8.9 (15/168) 13.8 (26/188) 12.7 (27/213) 0.33
Pain* 42.3 (58/137) 44.5 (77/173) 42.8 (74/173) 0.91
Fall risk 4.2 (7/165) 27.9 (57/204) 30.0 (72/240) ,0.001
Presence of a pressure ulcer 0.0 (0/141) 3.6 (7/196) 4.1 (10/245) 0.06
Indwelling urinary catheter 7.6 (13/172) 20.0 (42/210) 37.3 (94/252) ,0.001
Incontinence 14.5 (24/165) 23.8 (49/206) 24.3 (60/247) 0.04
Constipation 20.3 (35/172) 14.9 (31/208) 22.0 (55/250) 0.15
Psychological domain
Premorbid cognitive impairment 7.4 (9/121) 24.7 (43/174) 42.1 (91/216) ,0.001
Cognitive impairment at time of admission 10.9 (19/175) 34.6 (73/211) 64.8 (164/253) ,0.001
Depressive symptoms* 18.2 (25/137) 20.3 (35/172) 24.7 (42/170) 0.36
Prevalent delirium 2.3 (4/175) 19.2 (40/208) 29.7 (71/239) ,0.001
Functional domain
Premorbid ADL impairment 13.1 (23/175) 50.2 (106/211) 77.3 (194/251) ,0.001
Vision impairment 9.5 (16/169) 20.7 (41/198) 30.5 (75/246) ,0.001
Hearing impairment 13.0 (21/161) 18.1 (35/193) 23.3 (55/236) 0.04
Low health status score* 31.1 (42/135) 38.0 (65/171) 44.0 (74/168) 0.07
Social domain
High perceived caregiver burden 26.3 (31/118) 41.7 (70/168) 50.2 (111/221) ,0.001
Total number of geriatric conditions
{ (mean (SD)) 2.2 (1.3) 3.8 (2.1) 5.1 (1.8) ,0.001
*Not assessed in patients with severe cognitive impairment, defined as an MMSE score #15 at admission.
{not including pain, depressive symptoms and low health status score, as those were most frequently not measured in high risk patients. Only cognitive impairment at
admission was included in the total number of geriatric conditions.
ADL=activities of daily living, IADL=instrumental activities of daily living.
doi:10.1371/journal.pone.0029621.t002
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important risk factor for mortality [28,29]. This risk factor might
explain the still relatively high mortality rates of 27% and 30% in
the low- and intermediate-risk groups, respectively, up to one year
after admission.
Compared with the low-risk group, the intermediate group
showed an increased risk for functional decline at three months, but
this increased risk disappeared at one year. A clear association
between the high-risk group and mortality and functional decline
was demonstrated at both time points. Only one-third of this group
maintained baseline function one year after admission. This finding
could indicate that the intermediate group has more potential for
further rehabilitation after admission compared with the high-risk
group, which might be too frail. Research has demonstrated that
once patients begin to decline, they are more prone to further
decline, even if they have regained their initial level of functioning
[30,31]. More interestingly, one large study on functional decline at
the end of life clearly demonstrated that functional trajectories for
patients with both organ failure and frailty in the last year of life
demonstrated an almost continuous decline in ADL functioning,
starting with already many baseline impairments, whereas in
patients with end-stage cancer, this decline only starts in the last two
or three months of life and these patients predominantly have a
good level of ADL functioning [32]. In our study this might also be
visible; in the low risk group, many patients died, but did not have
much premorbid dependencies. These patients were more fre-
Table 3. Response to the ISAR-HP questions, baseline impairments and functional outcomes at three and twelve months in the
three risk groups for functional decline.
Low risk (n=175)
Intermediate risk
(n=211) High risk (n=253)
Response to ISAR-HP questions
1. Needed more help in IADL (% yes) 16.6 32.5 47.6
2. Eight years or fewer of formal education (% yes) 20.8 37.8 58.7
3. Needed help with travelling (% yes) 5.7 48.6 91.3
4. Use of a walking device (% yes) 0.0 56.4 100.0
Baseline functional characteristics
Katz ADL index
* (mean/SD) 0.14 (0.39) 1.16 (1.64) 2.36 (2.10)
No of baseline impairments on Katz ADL index (%)
0 86.9 49.8 22.7
1 12.6 23.7 24.7
2 0.0 10.0 11.2
3 0.6 5.2 8.8
4 0.0 3.8 10.8
5 0.0 3.8 12.0
6 0.0 3.8 10.0
Functional outcome at three months
Katz ADL index
* (mean/SD) 0.36 (0.76) 1.32 (1.87) 3.05 (2.10)
Functional decline
{ (mean/SD) 0.20 (0.77) 0.34 (1.47) 0.83 (1.83)
Functional outcome at twelve months
Katz ADL index
* (mean/SD) 0.41 (0.73) 1.40 (1.94) 2.77 (2.13)
Functional decline
{ (mean/SD) 0.24 (0.70) 0.51 (1.85) 0.68 (1.88)
ISAR-HP=identification of seniors at risk-hospitalized patients, IADL=instrumental activities of daily living, ADL=activities of daily living, SD=standard deviation.
*Katz ADL index; range of scores between 0–6, with a higher score indicating more dependence.
{Functional decline was measured with the Katz ADL index and the outcome at three or twelve months was compared to premorbid functioning two weeks prior to
hospital admission. These data were only available for those patients still alive at follow up.
doi:10.1371/journal.pone.0029621.t003
Table 4. Cox regression models for three- and twelve-month mortality in relation to risk categories.
Risk category
Three-month mortality
Unadjusted HR (95% CI)
Three-month mortality
Adjusted* HR (95% CI)
Twelve-month mortality
Unadjusted HR (95% CI)
Twelve-month mortality
Adjusted* HR (95% CI)
Low risk Ref Ref Ref Ref
Intermediate risk 1.49 (0.90–2.45) 1.43 (0.85–2.42) 1.15 (0.79–1.67) 1.10 (0.75–1.62)
High risk 1.82 (1.13–2.91) 1.71 (1.01–2.90) 1.81 (1.29–2.54) 1.62 (1.11–2.35)
HR=hazard ratio; CI=confidence interval.
*Adjusted for age, sex and Charlson comorbidity index.
doi:10.1371/journal.pone.0029621.t004
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baselineimpairmentswerepresent,and thesepatientsdemonstrated
most decline in the year after hospital admission.
An important question is whether risk status can identify the
patients most likely to benefit from multidisciplinary intervention
by a geriatric consultation team. Results of a meta analysis of
inpatient geriatric rehabilitation argued that subgroup evidence in
favor of providing geriatric rehabilitation during and after hospital
admission is warranted [33] and that more tailored approaches to
patient selection still need to be tested. A recent randomized
clinical trial (RCT) focusing on disease management in older heart
failure patients divided participants into three risk groups and
found that there was a difference in intervention benefits, in terms
of both outcomes and costs, in favor of the intermediate-risk group
[34]. The authors argued that the low-risk group was too healthy
and that the high-risk group too ill to profit from the intervention.
Further research should focus on testing this risk-based
approach in acutely hospitalized older patients. This research
could be implemented in two ways. The first is an impact study,
testing the clinical usefulness of the approach by determining
whether the risk assessment outcomes influence decision making
and goal setting in both physicians and patients [35]. The second
study that could be performed is an RCT using the three risk
groups as a basis for goal setting and intervention. The ICF
rehabilitation model could inform goals for the low-, intermediate-
and high-risk groups [10]. The ICF rehabilitation model identifies
several different health strategies, which can be used to determine
rehabilitation outcomes. The three health strategies that might be
relevant in relation to this study are the preventive health strategy,
in which the main purpose is to prevent health conditions and
remain functioning. The second strategy is aimed at rehabilitation
in which the primary goal should be to restore functioning and the
third strategy is supportive care direct towards maintaining quality
of life and preservation of autonomy. These strategies might be
relevant for the low, intermediate and high risk group,
respectively.
Some limitations need to be addressed. First, in our study, we
made a predefined selection with one risk assessment instrument,
the ISAR-HP. Our main purpose was to demonstrate that a risk
assessment instrument can be helpful to detect low-, intermediate-
and high-risk patients. Although our study is a multicenter study,
using the ISAR-HP for this purpose in other settings might
produce different arising from differences in the case mix of
patients, leading to a different distribution of the outcome and
predictive factors [35]. We clearly demonstrated that this risk-
based approach revealed differences in baseline (clinical) charac-
teristics and health outcomes, further enhancing the validity of this
screening instrument.
Second, functional decline was operationalized as a one-point
decline at follow-up functioning compared with premorbid
functioning. For further analyses, we dichotomized the outcome
as present or absent. Although this approach is used in most
studies of functional decline in hospitalized older patients [2], it
leads to a loss of information about the ADL functioning level after
hospitalization.
Third, the inclusion percentage was 62%. This expected but still
low inclusion rate is a common problem in studies of acutely
hospitalized older patients, and most trials conducted in this
population demonstrated equal or lower participation rates [36–
38]. We did conduct a small non-respondent analysis in which we
demonstrated that the patients that were excluded were often
younger and died more frequently after discharge. Presumably,
these patients more frequently had end stage diseases or were very
frail older patients. It would have strengthened the validity of study
results, if we would have collected more baseline information on
these patients.
Conclusion
In conclusion, by using an easily applied risk assessment
instrument at hospital admission, three patients groups (low,
intermediate and high risk for functional decline) with distinct
clinical characteristics could be distinguished. This approach
might contribute to better defining of treatment goals at hospital
admission, earlier initiation of appropriate (preventive) interven-
tions and better communication with patients and caregivers about
the preferred outcomes of admission. The application of this
approach and the effectiveness of risk-based clinical interventions
should further be tested in clinical practice and randomized
clinical trials.
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